MARKET

DBVT

DBVT

Dbv Technologies S A
NASDAQ
11.60
-0.57
-4.68%
After Hours: 11.60 0 0.00% 16:40 09/24 EDT
OPEN
11.95
PREV CLOSE
12.17
HIGH
12.12
LOW
11.27
VOLUME
333.46K
TURNOVER
--
52 WEEK HIGH
26.19
52 WEEK LOW
8.86
MARKET CAP
686.86M
P/E (TTM)
-3.2527
1D
5D
1M
3M
1Y
5Y
1D
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX)
TipRanks · 2d ago
Weekly Report: what happened at DBVT last week (0914-0918)?
Weekly Report · 3d ago
Weekly Report: what happened at DBVT last week (0907-0911)?
Weekly Report · 09/14 10:16
Weekly Report: what happened at DBVT last week (0831-0904)?
Weekly Report · 09/07 10:09
DBV Technologies to Participate in Upcoming September Investor Conferences
Barchart · 09/03 15:32
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026
Barchart · 09/02 16:55
Weekly Report: what happened at DBVT last week (0824-0828)?
Weekly Report · 08/31 10:16
Artisan International Small-Mid Fund Q2 2026 Portfolio Review
Seeking Alpha · 08/24 19:03
More
About DBVT
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Webull offers DBV Technologies SA - ADR stock information, including NASDAQ: DBVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DBVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DBVT stock methods without spending real money on the virtual paper trading platform.